Fisher & Paykel Healthcare (ASX: FPH) has reported its half year result to 30 September 2019.
Fisher & Paykel Healthcare Corp is a manufacturer, designer and marketer of products & systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The company has been operating in the healthcare industry since the 60s. The healthcare business has been a separate entity since 2001 when the company split from its appliances business.
FY20 Half Year Result
The healthcare business reported that in the half year period it grew operating revenue by 12%, or 9% in constant currency terms, to $570.9 million (all amounts are in New Zealand dollars).
It reported faster growth for its hospital operating revenue, it grew by 19%, or 17% in constant currency. Management attributed some of this result to an extended flu season in the US.
There was 23% constant currency revenue growth for new applications consumables, which are products used in non-invasive ventilation, Optiflow nasal high flow therapy, and surgical applications. The benefits continue to flow from the growing body of clinical research in the use of nasal high flow therapy.
There was 2% growth in homecare operating revenue (1% decline in constant currency) and a 1% decline in constant currency revenue in OSA masks.
Thanks to growth of higher profit products, the gross margin increased by 26 basis points (0.26%) to 67.1% which helped net profit rise by 23% to $121.2 million
Fisher & Paykel Dividend
The Board decided to declare an interim dividend of 12 cents per share, an increase of 23% compared to last year.
The company is expecting consistent underlying trends in the hospital product segment. Assuming a moderate flu season in FY20, growth in the second half of FY20 will be similar to the growth in FY19.
Homecare revenue in FY20 is expected to be similar to FY19 in constant currency terms.
Full year operating revenue is expected to be $1.19 billion and net profit after tax is predicted to be in a range of $255 million to $265 million.
Online Value Investing Course - FREE!
How do you value an investment? Do you really understand what you’re investing in and why?
We’ve just updated our FREE business valuation course and made it available to investors like you. Complete with models, templates and tools, simply click here to access the course.
It’s completely free!
Disclaimer and warning: The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms of Service and Financial Services Guide before using this website.
At the time of publishing, Jaz does not have a financial interest in any of the companies mentioned.